Hosseinzadegan Fariba, Radfar Moloud, Shafiee-Kandjani Ali Reza, Sheikh Naser
a Urmia University of Medical Sciences , Urmia , Iran.
b Tabriz University of Medical Sciences , Tabriz , Iran.
Int J Clin Exp Hypn. 2017 Jan-Mar;65(1):86-97. doi: 10.1080/00207144.2017.1246878.
Pain is common in patients with multiple sclerosis. This study evaluated self-hypnosis for pain control in that population. A randomized clinical trial was conducted on 60 patients, who were assigned to either a control group or to a self-hypnosis group, in which patients performed self-hypnosis at least 10 times a day. All patients were trained to score the perceived pain twice daily on a numerical rating scale and also reported the quality of pain with the McGill Pain questionnaire. Repeated-measures analysis showed a significant difference between the groups; pain was lower in the self-hypnosis group but was not maintained after 4 weeks. Self-hypnosis could effectively decrease the intensity and could modify quality of pain in female patients with multiple sclerosis.
疼痛在多发性硬化症患者中很常见。本研究评估了自我催眠对该人群疼痛控制的效果。对60名患者进行了一项随机临床试验,这些患者被分为对照组或自我催眠组,自我催眠组的患者每天至少进行10次自我催眠。所有患者均接受培训,每天两次用数字评分量表对感知到的疼痛进行评分,并通过麦吉尔疼痛问卷报告疼痛的性质。重复测量分析显示两组之间存在显著差异;自我催眠组的疼痛程度较低,但4周后未持续。自我催眠可有效降低女性多发性硬化症患者的疼痛强度,并可改善疼痛性质。